FDA Asks the Court to Delay First 55,000 Page Production Until May and Pfizer Moves to Intervene in the Lawsuit

As explained in prior posts, in a lawsuit seeking all of the documents the FDA relied upon to license Pfizer's COVID-19 vaccine, a federal judge shot down the FDA's requested rate of 500 pages per month and instead ordered the FDA to produce at the rate of 55,000 pages per month starting on March 1.

The FDA's excuse? As explained in the brief opposing the FDA's request, the FDA's defense effectively amounts to claiming that the 11 document reviewers it has already assigned and the 17 additional reviewers being onboarded are only capable of reading at the speed of preschoolers.

INTRODUCTION TO OPPOSITION TO FDA'S MOTION. It is understandable that the FDA does not want independent scientists to review the documents it relied upon to license Pfizer's vaccine given that it is not as effective as the FDA originally claimed, does not prevent transmission, does not prevent against certain emerging variants, can cause serious heart inflammation in younger individuals, and has numerous other undisputed safety issues.

If the FDA's 11 full-time reviewers work only 7.5 hours per day and review 50 pages per hour, the FDA could review over 88,000 pages per month in February and March.

The FDA, with over 18,000 employees and an over $3 billion discretionary budget, repeatedly assures the Court that it is taking steps to "Marshal every possible resource available to it," "Acting with maximal urgency to assemble every possible resource available to it" and "Putting every available resource at its disposal into its efforts to achieve compliance." The FDA also attests that over the coming weeks, it will have 28.5 full-time people reviewing the documents.

The Court is, other than Congress, the only check on the FDA. In a free country, transparency is paramount, and the FDA has chosen to thwart transparency and the requirements of FOIA by anemically understaffing the office it maintains to respond to FOIA requests.

Meaning, despite the FDA's claim the vaccine is "Effective," the FDA is apparently still scared to send a representative to the hearing.

Somewhere on the other side of the growing heap of government and pharma lawyers is transparency.

https://aaronsiri.substack.com/p/fda-asks-the-court-to-delay-first?s=09